NCT06720363 Development of a Predictive Model of Fetal PH At Birth from Novel Variables Derived from Cardiotocographic Tracing
| NCT ID | NCT06720363 |
| Status | Recruiting |
| Phase | — |
| Sponsor | IRCCS Azienda Ospedaliero-Universitaria di Bologna |
| Condition | Pregnancies At Increased Risk of Preterm Birth |
| Study Type | OBSERVATIONAL |
| Enrollment | 5,000 participants |
| Start Date | 2024-06-07 |
| Primary Completion | 2028-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 5,000 participants in total. It began in 2024-06-07 with a primary completion date of 2028-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to build a predictive model of fetal acidosis based on variables from the cardiotocographic tracing recorded during labor in participants undergoing spontaneous or induced delivery with single pregnancy.
Eligibility Criteria
Inclusion Criteria: * Maternal age between 18 and 45 years; * Single pregnancy * Participants undergoing continuous monitoring of labor labor * Obtaining informed consent for study participation and processing of personal data Exclusion Criteria: * None
Contact & Investigator
Antonio Farina, MD
PRINCIPAL INVESTIGATOR
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Frequently Asked Questions
Who can join the NCT06720363 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 45 Years, studying Pregnancies At Increased Risk of Preterm Birth. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06720363 currently recruiting?
Yes, NCT06720363 is actively recruiting participants. Contact the research team at antonio.farina@unibo.it for enrollment information.
Where is the NCT06720363 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06720363 clinical trial?
NCT06720363 is sponsored by IRCCS Azienda Ospedaliero-Universitaria di Bologna. The principal investigator is Antonio Farina, MD at IRCCS Azienda Ospedaliero-Universitaria di Bologna. The trial plans to enroll 5,000 participants.